Your browser doesn't support javascript.
loading
A vaccine targeting mutant IDH1 in newly diagnosed glioma.
Platten, Michael; Bunse, Lukas; Wick, Antje; Bunse, Theresa; Le Cornet, Lucian; Harting, Inga; Sahm, Felix; Sanghvi, Khwab; Tan, Chin Leng; Poschke, Isabel; Green, Edward; Justesen, Sune; Behrens, Geoffrey A; Breckwoldt, Michael O; Freitag, Angelika; Rother, Lisa-Marie; Schmitt, Anita; Schnell, Oliver; Hense, Jörg; Misch, Martin; Krex, Dietmar; Stevanovic, Stefan; Tabatabai, Ghazaleh; Steinbach, Joachim P; Bendszus, Martin; von Deimling, Andreas; Schmitt, Michael; Wick, Wolfgang.
Afiliación
  • Platten M; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany. m.platten@dkfz.de.
  • Bunse L; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany. m.platten@dkfz.de.
  • Wick A; Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany. m.platten@dkfz.de.
  • Bunse T; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Le Cornet L; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany.
  • Harting I; Neurology Clinic, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.
  • Sahm F; NCT, Heidelberg, Germany.
  • Sanghvi K; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tan CL; Department of Neurology, Medical Faculty Mannheim, MCTN, University of Heidelberg, Mannheim, Germany.
  • Poschke I; NCT Trial Center, NCT, Heidelberg, Germany.
  • Green E; Department of Neuroradiology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.
  • Justesen S; DKTK CCU Neuropathology, DKFZ, Heidelberg, Germany.
  • Behrens GA; Department of Neuropathology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.
  • Breckwoldt MO; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Freitag A; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Rother LM; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schmitt A; Immune Monitoring Unit, National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Schnell O; DKTK (German Cancer Consortium) Clinical Cooperation Unit (CCU) Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hense J; Immunitrack, Copenhagen, Denmark.
  • Misch M; DKMS Life Science Lab GmbH, Dresden, Germany.
  • Krex D; Department of Neuroradiology, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.
  • Stevanovic S; NCT Trial Center, NCT, Heidelberg, Germany.
  • Tabatabai G; NCT Trial Center, NCT, Heidelberg, Germany.
  • Steinbach JP; Department of Internal Medicine V, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.
  • Bendszus M; Department of Neurosurgery, University of Freiburg, Freiburg, Germany.
  • von Deimling A; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Schmitt M; Department of Neurosurgery, Charité Medical Center, University of Berlin, Berlin, Germany.
  • Wick W; Department of Neurosurgery, Carl Gustav Carus University Hospital, University of Dresden, Dresden, Germany.
Nature ; 592(7854): 463-468, 2021 04.
Article en En | MEDLINE | ID: mdl-33762734

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Glioma / Isocitrato Deshidrogenasa / Mutación Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Glioma / Isocitrato Deshidrogenasa / Mutación Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article